Literature DB >> 16983991

[Costs of medical care attributable to tobacco consumption at the Mexican Institute of Social Security (IMSS), Morelos].

Luz Myriam Reynales-Shigematsu1, Sergio Arturo Juárez-Márquez, Raydel Valdés-Salgado.   

Abstract

OBJECTIVE: To estimate the cost of medical care for the major diseases attributable to tobacco consumption at the IMSS, Morelos.
MATERIAL AND METHODS: A cost of illness (COI) analysis was carried out from the perspective of the health provider. An expert panel characterized medical care in primary and secondary care levels according to severity of disease. The smoking attributable fraction (SAF) by disease was used to derive costs attributable to tobacco consumption. The unitary cost was valuated in 2001 Mexican pesos (MP).
RESULTS: The estimated annual average cost of medical care (diagnosis and first year of treatment) was 79,530 MP for acute myocardial infarction (AMI); 73,303 MP for chronic obstructive pulmonary disease (COPD); and 102,215 MP for lung cancer (LC). The annual total cost of medical care for IMSS was 147,390 688 MP. The total annual cost of medical care attributable to tobacco consumption corresponds to dollars 124 million MP, which is equivalent to 7.3% of the annual budget of the Morelos Delegation.
CONCLUSIONS: These results confirm the high medical costs associated with smoking. A repetition of this study at the national level is recommended in order to support decision-makers in strengthening public policies to control tobacco use in Mexico.

Entities:  

Mesh:

Year:  2005        PMID: 16983991     DOI: 10.1590/s0036-36342005000600010

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

1.  Building capacity for tobacco control research and policy.

Authors:  F Stillman; G Yang; V Figueiredo; M Hernandez-Avila; J Samet
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

2.  Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security.

Authors:  Svetlana V Doubova; Stephane Roze; Aldo Ferreira-Hermosillo; Ricardo Pérez-Cuevas; Ricardo Gasca-Pineda; Casper Barsoe; Jonathan Baran; Brian Ichihara; Erick Gryzbowski; Kyla Jones; Juan E Valencia
Journal:  Cost Eff Resour Alloc       Date:  2019-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.